Company Overview
The Vimian Group AB (VIMIAN.ST) is a Swedish healthcare company headquartered in Stockholm. The firm focuses on animal health, offering specialty pharmaceuticals, diagnostics, medical technology, and veterinary services to customers worldwide. The company is listed on the Swedish Stock Exchange.
Recent Trading Performance
- Price as of 01:54 AM CET, Friday 23 Oct 2026: SEK 40.05
- 24‑hour change: flat (0 %)
- Volume: SEK 8 million traded in the last 24 hours
- Shares outstanding: 529.9 million
- Market capitalisation: SEK 20.2 billion
- 52‑week high: SEK 38.8 (19 Oct 2026)
- 52‑week low: SEK 24.18 (23 Mar 2026)
- Simple moving average (200 days): SEK 30.89
- Month‑to‑date change: up 7.49 %
Comparison with Peers (last 24 hours)
| Stock | Change | Current Price | Market Cap | P/E Ratio |
|---|---|---|---|---|
| Wallenstam –B (WALL‑B.ST) | –0.64 % | SEK 38.02 | SEK 23.8 bn | 8.18 |
| Tieto (TIETO.HE) | +1.8 % | EUR 19.43 | EUR 2.1 bn | 10.16 |
| Scandic Hotels (SHOT.ST) | +0.99 % | SEK 100.4 | SEK 21.9 bn | 30.23 |
| Addlife (ALIF‑B.ST) | +2.92 % | SEK 180.7 | SEK 23 bn | 39.08 |
Summary
Vimian’s share price remained unchanged over the most recent 24‑hour trading period, trading at SEK 40.05. The company’s market cap is SEK 20.2 billion, and it has generated a 24‑hour volume of SEK 8 million. Over the past month, the stock has risen by 7.49 %. Compared with selected peers, Vimian’s price has shown stability, while its peers have experienced modest gains or a slight decline. The 52‑week trading range for Vimian spans from SEK 24.18 to SEK 38.8, indicating moderate volatility within the year.
